Abstract
Immunization of mice, with preparations of heat shock proteins (HSPs) isolated from tumors or virus-infected cells, has been shown to elicit specific protective immunity against the tumor or the virus-infected cells used as the source of the HSP. This phenomenon has been shown to be general, in that specific immunogenicity of tumor-derived HSP preparations has been demonstrated in the cases of hepatoma (1), fibrosarcoma (2-8), lung carcinoma (9), prostate cancer (10), spindle cell carcinoma (9), colon carcinoma (9), and melanoma (9), in mice and rats of different haplotypes. These tumors include chemically induced (1-8), UV-induced (11) and spontaneous tumors (9), and efficacy has been demonstrated in prophylactic (1-8,10,11) as well as in therapeutic models (9). In the case of viral models, HSP preparations from cognate cells have been shown to elicit a virus-specific cellular immune response against influenza virus (12), SV40 (13), vesicular stomatitis virus (14) and lymphocytic choriomeningitis virus (15). HSP preparations from cells transfected with model antigens (Ags) such as ovalbumin and β-galactosidase have been shown to elicit Ag-specific cytotoxic T-lymphocytes (CTL)s against ovalbumin (16) or β-galactosidase, respectively (17)
The immunogenicity of HSP-peptide complexes has obvious applications in vaccination against cancers and infectious diseases (18). With respect to cancers, HSP-peptide complexes isolated from a patient’s cancer can serve as customized, patient-specific therapeutic vaccines (19).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Mosmann, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A., and Coffmann, R. L. (1986) Two types of murine helper T cell clone. I. Definition according to profile of lymphokine activities and secreted proteins. J. Immunol. 136, 2348–2357.
Gately, M. K., Renzetti, L. M., Magram, J., Stern, A., Adorini, L., Gubler, U., and Presky, D. H. (1998) Interleukin-12/interleukin-12 receptor system: role in normal and pathologic immune responses. Annu. Rev. Immunol. 16, 495–521.
Paul, W. E. and Seder, R. A. (1994) Lymphocytes responses and cytokines. Cell 76, 241–251.
Scott, B., Liblau, R., Degermann, S., Marconi, L. A., Ogata, L., Caton, A. J., McDevitt, H. O., and Lo, D. (1994) Role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity. Immunity 1, 1–20.
Hsieh, C., Macatonia, S. E., O’Garra, A., and Murphy, K. M. (1995) T cell genetic background determines default T helper phenotype development in vitro. J. Exp. Med. 181, 713–731.
Reiner, S. L. and Locksley, R. M. (1995) Regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13, 151–177.
Pfeiffer, C., Stein, J., Southwood, S., Ketelaar, H., Sette, A., and Bottomly, K. (1995) Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo. J. Exp. Med. 181, 1569–1574.
Nicholson, L. B., Greer, J. M., Sobel, R. A., Lees, M. B., and Kuchroo, V. K. (1995) Altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis. Immunity 3, 397–405.
Hosken, N. A., Shibuya, K., Heath, A. W., Murphy, K. M., and O’Garra, A. (1995) Effect of antigen dose on CD4+helper cell phenotype development in a T cell receptor-αβ-transgenic model. J. Exp. Med. 182, 1579–1584.
Constant, S., Pfeiffer, C., Woodard, A., Pasqualini, T., and Bottomly, K. (1995) Extent of T cell receptor ligation can determine the functional differentiation of naive CD4+T cells. J. Exp. Med. 182, 1591–1596.
Guéry, J.-C., Galbiati, F., Smiroldo, S., and Adorini, L. (1997) Non MHC-linked Th2 cell development induced by soluble protein administration predicts susceptibility to Leishmania major infection. J. Immunol. 159, 2147–2153.
Heinzel, F. P., Sadick, M. D., Holaday, B. J., Coffman, R. L., and Locksley, R. M. (1989) Reciprocal expression of interferon γ or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. J. Exp. Med. 169, 59–72.
Guéry, J.-C., Galbiati, F., Smiroldo, S., and Adorini, L. (1996) Selective development of Th2 cells induced by continuous administration of low dose soluble proteins to normal and β2-micr°gl°bulin-deficient BALB/c mice. J. Exp. Med. 183, 485–497.
Howard, J. G., Hale, C., and Chan-Liew, W. L. (1980) Immunological regulation of experimental cutaneous leishmaniasis. I. Immunogenetic aspects of susceptibility to Leishmania tropica in mice. Parasite Immunol. 2, 303–310.
Degermann, S., Pria, E., and Adorini, L. (1996) Soluble protein but not peptide administration diverts the immune response of a clonal CD4+T cell population to the T helper 2 pathway. J. Immunol. 157, 3260–3269.
De Wit, D., Van Mechelen, M., Ryelandt, M., Figueiredo, A. C., Abramowicz, D., Goldman, M., et al. (1992) Injection of deaggregated gamma globulins in adult mice induces antigen-specific unresponsiveness of T helper type 1 but not type 2 lymphocytes. J. Exp. Med. 175, 9–14.
Burstein, H. J., Shea, C. M., and Abbas, A. K. (1992) Aqueous antigens induce in vivo tolerance selectively in IL-2-and IFN-γ-producing (Th1) cells. J. Immunol. 148, 3687–3691.
Romball, C. G. and Weigle, W. O. (1993) In vivo induction of tolerance in murine CD4+cell subsets. J. Exp. Med. 178, 1637–1644.
Forsthuber, T., Yip, H. C., and Lehmann, P. V. (1996) Induction of Th1 and Th2 immunity in neonatal mice. Science 271, 1728–1731.
Prat, M., Gribaudo, G., Comoglio, P. M., Cavallo, G., and Landolfo, S. (1984) Monoclonal antibodies against murine γ interferon. Proc. Natl. Acad. Sci. USA 81, 4515–4519.
Cherwinski, H., Shumacher, J., Brown, K., and Mosmann, T. (1987) Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally mono-specific bioassays, and monoclonal antibodies. J. Exp. Med. 166, 1229–1244.
Galbiati, F., Rogge, L., Guéry, J.-C., Smiroldo, S., and Adorini, L. (1998) Regulation of the interleukin (IL)-12 receptor β2 subunit by soluble antigen and IL-12 in vivo. Eur. J. Immunol. 28, 209–220.
Szabo, S. J., Jacobson, A. G., Gubler, U., and Murphy, K. M. (1995) Developmental commitment to the Th2 lineage by extinction of IL-12 signaling. Immunity 2, 665–675.
Perez, V. L., Lederer, J. A., Lichtman, A. H., and Abbas, A. K. (1995) Stability of Th1 and Th2 populations. Int. Immunol. 7, 869–875.
Manetti, R., Gerosa, F., Giudici, M. G., Biagiotti, R., Parronchi, P., Piccinni, M.-P., et al. (1994) Interleukin 12 induces stable priming for interferon-γ (IFN-γ) production during differentiation of human T helper (Th) cells and transient IFN-γ production in established Th2 cell clones. J. Exp. Med. 179, 1273–1283.
Sornasse, T., Larenas, P. V., Davis, K. A., De Vries, J. E., and Yssel, H. (1996) Differentiation and stability of T helper 1 and 2 cells derived from naive human neonatal CD4+T cells, analyzed at the single-cell level. J. Exp. Med. 184, 473–483.
Szabo, S. J., Dighe, A. S., Gubler, U., and Murphy, K. M. (1997) Regulation of the interleukin (IL)-12R β2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J. Exp. Med. 185, 817–824.
Rogge, L., Barberis-Maino, L., Biffi, M., Passini, N., Presky, D. H., Gubler, U., and Sinigaglia, F. (1997) Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J. Exp. Med. 185, 825–831.
Presky, D. H., Yang, H., Minetti, L. J., Chua, A. O., Nabavi, N., Wu, C.-Y., Gately, M. K., and Gubler, U. (1996) Functional interleukin-12 receptor complex is composed of two β type cytokine receptor subunits. Proc. Natl. Acad. Sci. USA 93, 14,002–14,007.
Constant, S., Sant’Angelo, D., Pasqualini, T., Taylor, T., Levin, D., Flavell, R., and Bottomly, K. (1995) Peptide and protein antigen require distinct antigen-presenting cell subsets for the priming of CD4+T cells. J. Immunol. 154, 4915–4923.
Guéry, J.-C., Ria, F., Galbiati, F., Smiroldo, S., and Adorini, L. (1997) Mode of protein antigen administration determines preferential presentation of pep-tide-class II complexes by lymph node dendritic or B cells. Int. Immunol. 9, 9–15.
Saoudi, A., Simmonds, S., Huitinga, I., and Mason, D. W. (1995) Prevention of experimental allergic encephalomyelitis in rats by targeting autoantigen to B cells: 244 evidence that the protective mechanism depends on changes in the cytokine response and migratory properties of autoantigen-specific T cells. J. Exp. Med. 182, 335–344.
Guéry, J. C., Ria, F., Galbiati, F., and Adorini, L. (1997) Normal B cells fail to secrete IL-12. Eur. J. Immunol. 27, 1632–1639.
Koch, F., Stanzl, U., Jennewein, P., Janke, K., Heufler, C., Kaempgen, E., Romani, N. and Schuler, G. (1996) High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J. Exp. Med. 184, 741–746.
Cella, M., Scheidegger, D., Palmer-Lehmann, K., Lane, P., Lanzavecchia, A., and Alber, G. (1996) Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 184, 747–752.
Gorham, J. D., Guler, M. L., Steen, R. G., Mackey, A. J., Daly, M. J., Frederick, K., Detrich, W. F., and Murphy, K. M. (1996) Genetic mapping of a murine locus controlling development of T helper 1/T helper 2 type responses. Proc. Natl. Acad. Sci. USA 93, 12,467–12,471.
Mocci, S. and Coffman, R. L. (1995) Induction of a Th2 population from a polarized Leishmania-specific Th1 population by in vitro culture with IL-4. J. Immunol. 154, 3779–3787.
Murphy, E., Shibuya, K., Hosken, N., Openshaw, P., Maino, V., Davis, K., Murphy, K., and O’Garra, A. (1996) Reversibility of T helper 1 and 2 population is lost after long term stimulation. J. Exp. Med. 183, 901–913.
Mocci, S. and Coffman, R. L. (1997) Mechanism of in vitro T helper cell type 1 to T helper cell type 2 switching in highly polarized Leishmania major-specific T cell populations. J. Immunol. 158, 1559–1564.
Nabors, G. S., Afonso, L. C. C., Farrell, J. P., and Scott, P. (1995) Switch from a type 2 to a type 1 T helper cell response and cure of established Leishmania majorinfection in mice is induced by combined therapy with interleukin 12 and Pentostam. Proc. Natl. Acad. Sci. USA 92, 3142–3146.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Humana Press Inc.
About this protocol
Cite this protocol
Srivastava, P.K., Jaikaria, N.S. (2000). Methods of Purification of Heat Shock Protein-Peptide Complexes for Use as Vaccines Against Cancers and Infectious Diseases. In: Solheim, J.C. (eds) Antigen Processing and Presentation Protocols. Methods in Molecular Biology, vol 156. Humana Press. https://doi.org/10.1385/1-59259-062-4:175
Download citation
DOI: https://doi.org/10.1385/1-59259-062-4:175
Publisher Name: Humana Press
Print ISBN: 978-0-89603-745-8
Online ISBN: 978-1-59259-062-9
eBook Packages: Springer Protocols